CCI-779 in metastatic melanoma: A phase II trial of the California Cancer Consortium.

被引：0
|
作者：
Margolin, KA
Longmate, J
Baratta, T
Synold, T
Weber, J
Gajewski, T
Quirt, I
Christensen, S
Doroshow, JH
机构：
[1] Univ So Calif, Norris Canc Ctr, Los Angeles, CA USA
[2] Univ Chicago, Sch Med, Chicago, IL 60637 USA
[3] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
[4] Univ Calif Davis, Sacramento, CA 95817 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7523
引用
收藏
页码：715S / 715S
页数：1
相关论文
共 50 条
  • [31] The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation
    Asano, T
    Yao, YX
    Zhu, JJ
    Li, DH
    Abbruzzese, JL
    Reddy, SA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 331 (01) : 295 - 302
  • [32] A phase II study of temsirolimus (CCI-779) in patients with metastatic and/or locally advanced recurrent endometrial cancer previously treated with chemotherapy: NCIC CTG IND 160b
    Oza, A. M.
    Elit, L.
    Provencher, D.
    Biagi, J. J.
    Panasci, L.
    Sederias, J.
    Dancey, J. E.
    Tsao, S.
    Eisenhauer, E. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [33] A Phase II trial of VEGF-Trap in previously treated patients with metastatic colorectal cancer (PHL 050). A study of the PMH Phase II Consortium.
    Dhani, Neesha C.
    Cohen, Steven J.
    Bjarnason, Georg A.
    Kollmannsberger, Christian
    Virik, Kiran
    Brown, Jasmine
    Wang, Lisa
    Oza, Amit
    Chen, Alice
    Moore, Malcolm J.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3459S - 3459S
  • [34] A Phase II Trial of Vorinostat (Suberoylanilide Hydroxamic Acid) in Metastatic Breast Cancer: A California Cancer Consortium Study
    Luu, Thehang H.
    Morgan, Robert J.
    Leong, Lucille
    Lim, Dean
    McNamara, Mark
    Portnow, Jana
    Frankel, Paul
    Smith, David D.
    Doroshow, James H.
    Gandara, David R.
    Aparicio, Ana
    Somlo, George
    Wong, Carol
    CLINICAL CANCER RESEARCH, 2008, 14 (21) : 7138 - 7142
  • [35] Phase II study of oxaliplatin in patients with unresectable, metastatic, or recurrent hepatocellular cancer - A California cancer consortium trial
    Yen, Y.
    Lim, Dean W.
    Chung, Vincent
    Morgan, Robert J.
    Leong, Lucille A.
    Shibata, Stephen I.
    Wagnian, Stephen D.
    Marx, Howard
    Chu, Peiguo G.
    Longmate, Jeffre V. A.
    Lenz, Heinz-Josef
    Rainanathan, Rainesh A.
    Belani, Chandra P.
    Gandara, David R.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (04): : 317 - 322
  • [36] A Phase 2 Study of Temsirolimus (CCI-779) in Patients With Soft Tissue Sarcomas A Study of the Mayo Phase 2 Consortium (P2C)
    Okuno, Scott
    Bailey, Howard
    Mahoney, Michelle R.
    Adkins, Douglas
    Maples, William
    Fitch, Tom
    Ettinger, David
    Erlichman, Charles
    Sarkaria, Jann N.
    CANCER, 2011, 117 (15) : 3468 - 3475
  • [37] A Phase II Study of Temsirolimus (CCI-779) in Combination with Rituximab in Patients with Relapsed or Refractory Mantle Cell Lymphoma.
    Ansell, Stephen M.
    Tang, Hui
    Kurtin, Paul
    Koenig, Patricia
    Inwards, David J.
    Shah, Keith
    Witzig, Thomas E.
    BLOOD, 2009, 114 (22) : 664 - 665
  • [38] Oblimersen and α-interferon in metastatic renal cancer: a phase II study of the California Cancer Consortium
    Kim Margolin
    Timothy W. Synold
    Primo Lara
    Paul Frankel
    Simon F. Lacey
    David I. Quinn
    Tracey Baratta
    Janice P. Dutcher
    Bixin Xi
    Don J. Diamond
    David R. Gandara
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 705 - 711
  • [39] N997B: Phase II trial of CCI-779 in recurrent glioblastoma multiforme (GBM): Updated results and correlative laboratory analysis.
    Galanis, E
    Buckner, JC
    Maurer, MJ
    Hidalgo, M
    Kreisberg, JI
    Peralba, J
    Jenkins, RB
    Walsh, DJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 115S - 115S
  • [40] Oblimersen and α-interferon in metastatic renal cancer:: a phase II study of the California Cancer Consortium
    Margolin, Kim
    Synold, Timothy W.
    Lara, Primo
    Frankel, Paul
    Lacey, Simon F.
    Quinn, David I.
    Baratta, Tracey
    Dutcher, Janice P.
    Xi, Bixin
    Diamond, Don J.
    Gandara, David R.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2007, 133 (10) : 705 - 711
12345